Get started
Tell us how close your next inspection is. We will set up the right workspace for the moment you are in.
Phase 1 · Days or weeks away
Close gaps and rehearse before inspectors arrive.
Start Phase 1Phase 2 · Inspectors on site
Respond quickly, consistently and with evidence.
Start Phase 2Phase 3 · Always-on awareness
Build the habits that keep surprises away.
Start Phase 3Not sure which fits? Sign up for any phase and we will help you move between them as your situation changes.
Free snapshots, built from public regulatory data.
Inspection history, citation trends, and 483 and warning-letter patterns for an FDA investigator.
Request snapshotInspection history, enforcement actions and a benchmark view for a supplier site.
Request snapshotPharma · GMP, CMC, readiness
Medical devices · ISO 13485, MDR, CAPA
Biotech · Clinical quality, first inspections
CDMO / CMO · Client audits, supplier oversight
Three sample environmental-monitoring events share a location and a similar observation. This is a pattern to review, not a confirmed root cause.
Ask the quality lead to examine the recurring pattern and its context before deciding whether an investigation or a corrective action is appropriate.
No real record was updated. In the proposed product, your team would determine the next action after checking the underlying evidence.